Latest filing published 07 Feb 2022 for Ocular Therapeutix, INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael H. Goldstein: trading record in brief
This profile gathers the share dealings of Michael H. Goldstein in Ocular Therapeutix, Inc, where the filings describe the role as chief executive. We count 3 filings; the first trade dates from 15 March 2019 and the latest from 3 February 2022.
The open-market record is one-sided, with 2 purchases worth €64k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant.
On 7 February 2022 came the latest disclosure, a share grant in Ocular Therapeutix, Inc. The latest purchase dates back some time: it was published 2,720 days ago, on 30 May 2019. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael H. Goldstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 63,333 shares0Common StockSEC:0001104659-22-012919:0
1 of 1 declaration
